APP and Alzheimer disease: Nano polymer carriers of EGCG, which could cross the BBB, enhanced synaptogenesis, memory, and learning processes by reducing Aβ and BACE1 protein expression in the hippocampus of APP/PS1 mice, a mouse model of AD [121].